- Home
- RPRX vs LECO Comparison
RPRX vs LECO Comparison
Compare RPRX & LECO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RPRX
- LECO
- Stock Information
- Founded
- RPRX 1996
- LECO 1895
- Country
- RPRX United States
- LECO United States
- Employees
- RPRX N/A
- LECO N/A
- Industry
- RPRX Biotechnology: Pharmaceutical Preparations
- LECO Industrial Machinery/Components
- Sector
- RPRX Health Care
- LECO Industrials
- Exchange
- RPRX Nasdaq
- LECO Nasdaq
- Market Cap
- RPRX 15.6B
- LECO 13.4B
- IPO Year
- RPRX 2020
- LECO N/A
- Fundamental
- Price
- RPRX $36.03
- LECO $236.00
- Analyst Decision
- RPRX Strong Buy
- LECO Buy
- Analyst Count
- RPRX 4
- LECO 9
- Target Price
- RPRX $44.50
- LECO $239.56
- AVG Volume (30 Days)
- RPRX 5.2M
- LECO 327.4K
- Earning Date
- RPRX 11-05-2025
- LECO 10-30-2025
- Dividend Yield
- RPRX 2.44%
- LECO 1.27%
- EPS Growth
- RPRX 54.86
- LECO 0.60
- EPS
- RPRX 2.32
- LECO 8.90
- Revenue
- RPRX $2,305,243,000.00
- LECO $4,098,850,999.00
- Revenue This Year
- RPRX $35.14
- LECO $7.09
- Revenue Next Year
- RPRX $1.24
- LECO $5.64
- P/E Ratio
- RPRX $15.51
- LECO $26.57
- Revenue Growth
- RPRX 3.02
- LECO 0.10
- 52 Week Low
- RPRX $24.05
- LECO $161.11
- 52 Week High
- RPRX $38.00
- LECO $249.19
- Technical
- Relative Strength Index (RSI)
- RPRX 51.05
- LECO 48.03
- Support Level
- RPRX $35.36
- LECO $229.99
- Resistance Level
- RPRX $36.67
- LECO $241.78
- Average True Range (ATR)
- RPRX 0.74
- LECO 4.92
- MACD
- RPRX 0.08
- LECO -0.36
- Stochastic Oscillator
- RPRX 68.36
- LECO 44.96
About RPRX Royalty Pharma plc
Royalty Pharma PLC is the largest buyer of biopharmaceutical royalties. The firm has a portfolio of royalties that entitles it to payments based on the sales of biopharma products. Royalty Pharma receives royalties on more than 35 commercial products, including AbbVie and Johnson & Johnson's Imbruvica (for chronic lymphocytic leukemia and other blood cancers), Biogen's Tysabri (for relapsing forms of multiple sclerosis), Vertex's cystic fibrosis franchise, and 10 development-stage product candidates.
About LECO Lincoln Electric Holdings Inc.
Lincoln Electric is a leading manufacturer of welding, cutting, and brazing products. Its portfolio includes arc-welding solutions, plasma and oxy-fuel cutting systems, and brazing and soldering alloys, as well as automation solutions. Lincoln Electric serves clients in the general fabrication, heavy industries, automotive, construction, shipbuilding, energy, and process industries, among other end markets. Based in Cleveland, Lincoln Electric has operations in 19 countries and has 11,000 employees worldwide. The company generated roughly $4 billion in sales in 2024.